CJC-1295 (No DAC) (5mg) / Ipamorelin (5mg)

Description

What is the CJC-1295 (No DAC) / Ipamorelin blend?

This blend offers two complementary peptides — CJC-1295 No DAC (a modified GHRH) and Ipamorelin (a GHSR agonist) — for combined preclinical research on endogenous growth hormone regulation.

• CJC-1295 No DAC is a modified growth hormone-releasing hormone fragment (1–29) engineered to stimulate pulse-like GH secretion with a short half-life of approximately 30 minutes, suited to studies involving natural temporal activation of the GH axis.
• Ipamorelin is a pentapeptide ghrelin receptor agonist (sequence Aib–His–D-2-Nal–D-Phe–Lys–NH₂) that selectively prompts GH release without affecting cortisol or prolactin in research models.

This dual formulation supports synergistic GH-axis investigations: CJC-1295 No DAC initiates hypothalamic GHRH receptor activation, while Ipamorelin enhances GH secretion via ghrelin receptor pathways, offering a near-physiological mimicry of GH pulsation in experimental frameworks.

Citations

• Peptides.org monograph: CJC-1295 No DAC is a short-acting GHRH(1–29) analogue (half-life ~30 min), distinct from the DAC variant.
• Peptides.org: “CJC-1295 No DAC: modified GRF(1–29) mimics endogenous GHRH pulse, suited to acute GH-axis studies.”
• PubChem Compound Summary for Ipamorelin (CID 9831659): sequence Aib–His–D-2-Nal–D-Phe–Lys–NH₂; formula C₃₈H₄₉N₉O₅; MW 711.9 Da.
• Peptides.guide entry: Ipamorelin is a selective GHSR agonist promoting GH release without cortisol or prolactin release, used in muscle growth and body composition research.

This product is supplied for laboratory research use only. Most evidence comes from animal studies and early-stage research.

Research Use Only
This product is sold exclusively as a research chemical for in-vitro laboratory investigation by qualified researchers. It is not a drug, not a dietary supplement, and not intended for human or veterinary consumption, diagnostic use, or any form of therapeutic application. No statement on this page should be read as medical advice or as a claim that this compound treats, prevents, or cures any condition. Findings referenced above are drawn from published preclinical and clinical literature and are provided for scientific reference only.